The cannabis industry has grown at a tremendous pace in the recent years due to the continuing legalization efforts seen around the world. The rapid growth of the industry has now caught the attention of Wall Street's financial institutions as well, who have begun to cover the marketplace. Investment banks such as Piper Jaffray, RBC Capitals, and Cowen have backed the industry by covering public companies that are dabbling with cannabis. For example, RBC Capitals analyst Nik Modi believes that cannabis is the next up and coming global industry. Modi expects the legal U.S. cannabis market to grow at a projected CAGR of 17% and reach as much as USD 47 Billion within the next decade. Currently, the medical cannabis sector accounts for a majority of the overall market share, however, Modi suggests that the industry will continue to be driven by the rising growth in the recreational sector. So far, only Canada and Uruguay have decided to legalize cannabis entirely, yet, the U.S. is still the biggest market driver. Even though the U.S. only has 10 states and the District of Columbia that have legalized cannabis entirely, states such as California, Colorado, and Nevada deliver over a billion dollars in annual revenue off of cannabis sales. Overall, as more states and countries move to legalize cannabis, cannabis is expected to flourish and become the next disruptive global market. CLS Holdings, USA Inc. (OTC: CLSH) (CSE: CLSH.U), Pyxus International Inc. (NYSE: PYX), HEXO Corp. (NYSE: HEXO) (TSX: HEXO), Charlotte's Web Holdings, Inc. (OTC: CWBHF) (CSE: CWEB), The Green Organic Dutchman Holdings Ltd. (OTC: TGODF) (TSX: TGOD)

The potential future revenues for the cannabis global market is unknown, but each report projects growth, growth and more growth. The renowned Bank of Montreal (BMO) had two of the bank's cannabis sector analysts, to seek: "… to determine just how big the total addressable market Canadian producers will be competing for in the coming years, one that doesn't stop at Canada's borders." said an article in the Financial Post. The article revealed what the bank's report said: "The potential of the global cannabis industry is so vast that it could eventually make the sky-high valuations of some Canadian licensed producers look like bargains, according to a new report from Bank of Montreal. Assuming a blue-sky scenario in which the U.S. and all 28 countries in the EU legalize marijuana for both recreational and medical use -- and in which Latin America allows the medical use of cannabis -- they project that in seven years the market could reach $194 billion, a number that significantly dwarfs the $5.9 billion in potential revenue they anticipate will be generated by the Canadian medical and recreational markets." Active Companies from around the market with current developments this week include: MYM Nutraceuticals Inc. (CSE: MYM) (OTC: MYMMF), The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), Aphria Inc. (NYSE: APHA) (TSX: APHA), HEXO Corp. (NYSE: HEXO) (TSX: HEXO), Newstrike Brands (TSX-V: HIP) (OTC: NWKRF).

Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at how the craft beer industry and the CBD sector are joining forces to bring CBD infused beer to consumers.